• cryo-EM Facility to Speed Drug Discovery

News & Views

cryo-EM Facility to Speed Drug Discovery

Oct 20 2020

Biotechnology company Proteros has announced plans to build a leading Centre of Excellence for industrial cryo-EM applications to improve success rates in drug discovery. Focusing on technologically challenging targets, the centre will expand the company’s expertise in protein science and protein crystallography, while representing another step towards making cryo-EM a routine industrial application in drug discovery.

Proteros is collaborating with Thermo Fisher Scientific to develop the experimental methods, protein sample preparation processes and workflows, as part of a programme that encourages pharmaceutical and biotechnology companies to engage with contract research organisations (CRO’s) that can offer cryoEM start up and development packages. This will enable participants to assess the potential of their samples before committing to costs of further development in-house or through CRO service contracts.

Proteros also announced the formation of a cryo-EM consortium that will offer industry partners dedicated access to microscope time and preferred access to Proteros’ protein science capabilities. Membership will provide hands on cryo-EM training, data processing and interpretation sessions.

 Dr. Stephan Krapp, Director Structural Biology at Proteros commented “Customers will benefit from our expertise in protein science and an experienced cryo-EM team, including expertise in protein crystallography. This initiative will advance cryo-EM toward routine application in drug discovery by enabling the study of proteins not accessible by x-ray crystallography.”

The Proteros cryo-EM facility (Munich) will feature a Thermo Scientific Glacios Cryo-TEM with advanced Falcon 4 direct electron detector and will be co-located at Proteros’ Munich headquarters alongside the Protein Sciences department. Proteros has one of the largest dedicated Protein Sciences teams staffed with more than 50 experts enabling it to deliver fit for purpose protein constructs of the highest quality.

 “Collaborating with Proteros to meet the cryo-EM needs of customers will accelerate biopharmaceutical research and development and will also encourage more scientists to embrace cryo-EM for their drug discovery research,” said Raymond Schrijver, senior director of electron microscopy for pharma at Thermo Fisher. “Cryo-EM is taking structure-based drug design into a new era, and the rapid adoption of this technique will have a direct impact on drug discovery and medical treatments.”

Further information at www.proteros.de


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

View all events